Market revenue in 2023 | USD 736.0 million |
Market revenue in 2030 | USD 1,091.3 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 75.72% in 2023. Horizon Databook has segmented the Mexico healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is a popular destination for outsourcing clinical trials due to its cost-effective options, proximity to the U.S., and the availability of investigators in urban areas. The country’s large and diverse patient pool, the establishment of the Federal Commission for Protection against Sanitary Risk (COFEPRIS), and the reduced set-up time for clinical trials to 2 months are contributing to its attractiveness.
In addition, significant investments are being made in infrastructure development to provide better facilities for clinical trials and medical tourism. Mexico’s largest hospital chain has invested around USD 700 million to build 15 new hospitals.
The average time required to set up a clinical trial process in Mexico is 3 to 4 months, which is relatively short compared to other countries. These factors have contributed to the healthcare CRO market growth in Mexico.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Mexico healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account